Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review.

ABSTRACT:

Purpose

Intellectual disability (ID) is a chronic neurodevelopmental condition characterised by limitations in intelligence and adaptive skills with an onset prior to the age of 18 years. People with ID have complex healthcare needs and are more likely than the general population to experience multiple comorbidities and polypharmacy, with subsequent increased risk of adverse medication effects. The aim of this scoping review is to characterise rating scales used to measure adverse effects of medication in people with ID.

Methods

Four online databases (PsycINFO, Medline, Web of Science and OpenGrey) were searched in April 2020. Studies were assessed for inclusion against pre-specified eligibility criteria. Reference lists of included studies were hand searched. Data extractio

SUBMITTER: Kelly N 

PROVIDER: S-EPMC9546988 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature